James L. Riley
Affiliations: | University of Pennsylvania Medical School, Philadelphia, PA, United States | ||
| 1989 | Vanderbilt University, Nashville, TN | ||
| 1994 | Emory University, Atlanta, GA |
Google:
"James Riley"Parents
Sign in to add mentor| Charles Singleton | grad student | (Neurotree) | |
| Jeremy Boss | grad student | 1994 | Emory (BME Tree) |
Children
Sign in to add trainee| Rachel Leibman | grad student | 2011- | University of Pennsylvania Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou Y, Jadlowsky J, Baiduc C, et al. (2023) Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. Plos Pathogens. 19: e1011853 |
| Wyatt MM, Huff LW, Nelson MH, et al. (2023) Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cell therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Ellis GI, Deng MZ, Winn DW, et al. (2022) Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation. Star Protocols. 3: 101784 |
| Addison MM, Ellis GI, Leslie GJ, et al. (2022) HIV-1-Infected CD4 T Cells Present MHC Class II-Restricted Epitope via Endogenous Processing. Journal of Immunology (Baltimore, Md. : 1950). 209: 864-873 |
| Kim GB, Fritsche J, Bunk S, et al. (2022) Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy. Science Translational Medicine. 14: eabo6135 |
| Ellis GI, Riley JL. (2022) How to kill T cells for immunotherapy. Nature Cancer. 1: 1134-1135 |
| Pawlicki JM, Cookmeyer DL, Maseda D, et al. (2021) NPM-ALK induces reprogramming of mature TCR-stimulated T cells resulting in de-differentiation and malignant transformation. Cancer Research |
| Ellis GI, Sheppard NC, Riley JL. (2021) Genetic engineering of T cells for immunotherapy. Nature Reviews. Genetics |
| Zhou Y, Maldini CR, Jadlowsky J, et al. (2021) Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy. The Journal of Infectious Diseases. 223: 38-45 |
| Tebas P, Jadlowsky JK, Shaw PA, et al. (2021) CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication. The Journal of Clinical Investigation |